Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADA-PAF: Antiarrhythmic Drugs for AF in SSS Patients
NCT02145546Phase 4Unknown
- Sponsor
- Xinhua Hospital
- Start
- May 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiodarone, sotalol, propafenone in Atrial fibrillation (AFib), sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
amiodaronesotalolpropafenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02145546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145546.